RxDoctor Payments Data

Carley Anderson, PA

Physician Assistant · Carlsbad, CANPI 1275158305

Payments from drug & device makers

$2,707in general payments, 2019–2025

Across 97 payments — averaging $27.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$587
  • AstraZeneca$287
  • Boston Scientific$280
  • Lilly USA, LLC$242
  • Edwards Lifesciences$173
  • Novo Nordisk$167
  • plus $971 from 17 others

What the payments were for

  • Food & beverage$2,707100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,707 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$13,268
Medicare patients
58
Services billed
191

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide13$20,272
JardianceEmpagliflozin13$12,250
Pregabalin17$1,273
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen19$1,155
Atorvastatin Calcium71$684
Albuterol Sulfate HfaAlbuterol Sulfate26$595
Levothyroxine Sodium35$390
Rosuvastatin Calcium22$361
Hydroxyzine Pamoate14$326
Cyclobenzaprine Hcl16$295
Oxycodone Hcl13$274
Gabapentin35$253
Losartan Potassium36$186
Trazodone Hcl23$184
Lisinopril36$174

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$167$20,27213 claims
Boehringer IngelheimJardiance$26$12,25013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Carlsbad

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →